Ceftazidime Injection, Powder, For Solution
Product Images NDC 25021-128

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ceftazidime (NDC 25021-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefa2 0013 01

Chemical structure of Ceftazidime showing its molecular components including the beta-lactam ring, side chains, and associated pyridinium salt with 5 molecules of water of hydration.*

FDA Label Image

Cefa2 0014 02

Label for Ceftazidime 1 g per vial injection, equivalent to 1 g of anhydrous ceftazidime. The single-dose vial is labeled for intravenous or intramuscular use. Manufactured by Sagent Pharmaceuticals, with storage and reconstitution instructions provided on the label.*

FDA Label Image

Cefa2 0014 03

Label for Ceftazidime 2 g per vial for injection, USP, single-dose vial. The label is from Sagent Pharmaceuticals, made for them in Brazil. It includes dosing and storage instructions, NDC 25021-128-50, and emphasizes use for intravenous administration only. The label features the Sagent logo with green and brown color elements and a designated varnish free area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.